Emergent BioSolutions Inc. (EBS)

NYSE: EBS · Real-Time Price · USD

5.85

-0.05 (-0.85%)

At close: Nov 5, 2026, 4:00 PM EST

5.76

-0.09 (-1.54%)

After-hours: Nov 5, 2026, 7:30 PM EST

Emergent BioSolutions Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	649.1	742.9	1,044	1,049	1,118	1,774
Revenue Growth	-17.72%	-28.81%	-0.54%	-6.10%	-36.99%	12.45%
Gross Profit	281.8	367.3	311.6	254.2	290.1	793.2
Operating Income	37.7	115.6	-52.2	-168.1	-109.3	386
Net Income	-260.7	52.6	-190.6	-760.5	-211.6	219.5
Earnings Per Share	-5.04	0.93	-3.60	-14.85	-4.22	4.06
EPS Growth	-	-	-	-	-	-28.52%

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Commercial Products	177.2	226.1	398.9	497.3	386.6	438
Mcm Products	428.4	456.7	509.8	447.2	579.6	585.9
ALL Other	43.5	60.1	134.9	104.8	-	-
Total	649.1	742.9	1,044	1,049	1,118	1,774

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	175.7	205.4	99.5	111.7	651.1	576.1
Total Debt	513.7	583.7	676.1	877.5	1,426	877.1
Net Cash (Debt)	-338	-378.3	-576.6	-765.8	-775.3	-301
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-6.53	-6.67	-10.88	-14.96	-15.48	-5.56

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	200.1	170.6	58.7	-206.3	-34.1	320.2
Capital Expenditures	-11.7	-13.8	-22.9	-51.6	-115.8	-224.1
Free Cash Flow	188.4	156.8	35.8	-257.9	-149.9	96.1
Free Cash Flow Growth	13357.14%	337.99%	-	-	-	-75.67%

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	43.41%	49.44%	29.86%	24.23%	25.96%	44.72%
Operating Margin	5.81%	15.56%	-5.00%	-16.02%	-9.78%	21.76%
Pretax Margin	-36.97%	11.15%	-13.69%	-69.68%	-19.60%	17.10%
Profit Margin	-40.16%	7.08%	-18.26%	-72.48%	-18.93%	12.38%
FCF Margin	29.03%	21.11%	3.43%	-24.58%	-13.41%	5.42%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	12.34	-	-	-	10.65
Forward PE	6.69	4.16	12.57	20.50	51.15	7.19
P/FCF Ratio	1.60	4.14	14.47	-	-	24.34
PS Ratio	0.46	0.87	0.50	0.12	0.53	1.32